SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-005222
Filing Date
2017-05-15
Accepted
2017-05-15 16:03:48
Documents
62
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0317_yewbiopharm.htm 10-Q 583806
2 CERTIFICATION f10q0317ex31i_yewbiopharm.htm EX-31.1 10057
3 CERTIFICATION f10q0317ex31ii_yewbiopharm.htm EX-31.2 10059
4 CERTIFICATION f10q0317ex32_yewbiopharm.htm EX-32 5011
  Complete submission text file 0001213900-17-005222.txt   3958671

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20170331.xml EX-101.INS 725508
6 XBRL SCHEMA FILE yewb-20170331.xsd EX-101.SCH 55454
7 XBRL CALCULATION FILE yewb-20170331_cal.xml EX-101.CAL 41877
8 XBRL DEFINITION FILE yewb-20170331_def.xml EX-101.DEF 134025
9 XBRL LABEL FILE yewb-20170331_lab.xml EX-101.LAB 452522
10 XBRL PRESENTATION FILE yewb-20170331_pre.xml EX-101.PRE 275466
Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148
Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 17844144
SIC: 0100 Agricultural Production-Crops